|
1
|
Kopelman PG: Obesity as a medical problem.
Nature. 404:635–643. 2000.PubMed/NCBI
|
|
2
|
Ahima RS and Flier JS: Adipose tissue as
an endocrine organ. Trends Endocrinol Metab. 11:327–332. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Havel PJ: Control of energy homeostasis
and insulin action by adipocyte hormones: leptin, acylation
stimulating protein, and adiponectin. Curr Opin Lipidol. 13:51–59.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spiegelman BM and Flier JS: Obesity and
the regulation of energy balance. Cell. 104:531–543. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bays HE: 'Sick fat', metabolic disease,
and atherosclerosis. Am J Med. 122(Suppl): S26–S37. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Melnikova I and Wages D: Anti-obesity
therapies. Nat Rev Drug Discov. 5:369–370. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cao Z, Umek RM and McKnight SL: Regulated
expression of three C/EBP isoforms during adipose conversion of
3T3-L1 cells. Genes Dev. 5:1538–1552. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Farmer SR: Transcriptional control of
adipocyte formation. Cell Metab. 4:263–273. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stephens JM, Morrison RF and Pilch PF: The
expression and regulation of STATs during 3T3-L1 adipocyte
differentiation. J Biol Chem. 271:10441–10444. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang K, Guo W, Yang Y and Wu J:
JAK2/STAT3 pathway is involved in the early stage of adipogenesis
through regulating C/EBPβ transcription. J Cell Biochem.
112:488–497. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martini CN, Plaza MV and Vila MC:
PKA-dependent and independent cAMP signaling in 3T3-L1 fibroblasts
differentiation. Mol Cell Endocrinol. 298:42–47. 2009. View Article : Google Scholar
|
|
12
|
Zhou Y, Wang D, Li F, Shi J and Song J:
Different roles of protein kinase C-betaI and -δ in the regulation
of adipocyte differentiation. Int J Biochem Cell Biol.
38:2151–2163. 2006. View Article : Google Scholar
|
|
13
|
Prusty D, Park BH, Davis KE and Farmer SR:
Activation of MEK/ERK signaling promotes adipogenesis by enhancing
peroxisome proliferator-activated receptor gamma (PPARgamma) and
C/EBPalpha gene expression during the differentiation of 3T3-L1
preadipocytes. J Biol Chem. 277:46226–46232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen LS, Redkar S, Taverna P, Cortes JE
and Gandhi V: Mechanisms of cytotoxicity to Pim kinase inhibitor,
SGI-1776, in acute myeloid leukemia. Blood. 118:693–702. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nawijn MC, Alendar A and Berns A: For
better or for worse: the role of Pim oncogenes in tumorigenesis.
Nat Rev Cancer. 11:23–34. 2011. View
Article : Google Scholar
|
|
16
|
Cervantes-Gomez F, Chen LS, Orlowski RZ
and Gandhi V: Biological effects of the Pim kinase inhibitor,
SGI-1776, in multiple myeloma. Clin Lymphoma Myeloma Leuk. 13(Suppl
2): S317–S329. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Behan JW, Yun JP, Proektor MP, Ehsanipour
EA, Arutyunyan A, Moses AS, Avramis VI, Louie SG, Butturini A,
Heisterkamp N and Mittelman SD: Adipocytes impair leukemia
treatment in mice. Cancer Res. 69:7867–7874. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nga ME, Swe NN, Chen KT, Shen L, Lilly MB,
Chan SP, Salto-Tellez M and Das K: PIM-1 kinase expression in
adipocytic neoplasms: diagnostic and biological implications. Int J
Exp Pathol. 91:34–43. 2010. View Article : Google Scholar
|
|
19
|
Meloche J, Paulin R, Courboulin A, Lambert
C, Barrier M, Bonnet P, Bisserier M, Roy M, Sussman MA, Agharazii M
and Bonnet S: RAGE-dependent activation of the oncoprotein Pim1
plays a critical role in systemic vascular remodeling processes.
Arterioscler Thromb Vasc Biol. 31:2114–2124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
More KN, Jang HW, Hong VS and Lee J: Pim
kinase inhibitory and antiproliferative activity of a novel series
of meridianin C derivatives. Bioorg Med Chem Lett. 24:2424–2428.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park YK, Lee TY, Choi JS, Hong VS, Lee J,
Park JW and Jang BC: Inhibition of adipogenesis and leptin
production in 3T3-L1 adipocytes by a derivative of meridianin C.
Biochem Biophys Res Commun. 452:1078–1083. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song NJ, Yoon HJ, Kim KH, Jung SR, Jang
WS, Seo CR, Lee YM, Kweon DH, Hong JW, Lee JS, et al: Butein is a
novel anti-adipogenic compound. J Lipid Res. 54:1385–1396. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rosen ED and Spiegelman BM: Molecular
regulation of adipogenesis. Annu Rev Cell Dev Biol. 16:145–171.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Linhart HG, Ishimura-Oka K, DeMayo F, Kibe
T, Repka D, Poindexter B, Bick RJ and Darlington GJ: C/EBPalpha is
required for differentiation of white, but not brown, adipose
tissue. Proc Natl Acad Sci USA. 98:12532–12537. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shang CA and Waters MJ: Constitutively
active signal transducer and activator of transcription 5 can
replace the requirement for growth hormone in adipogenesis of
3T3-F442A preadipocytes. Mol Endocrinol. 17:2494–2508. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang D, Zhou Y, Lei W, Zhang K, Shi J, Hu
Y, Shu G and Song J: Signal transducer and activator of
transcription 3 (STAT3) regulates adipocyte differentiation via
peroxisome-proliferator-activated receptor gamma (PPARgamma). Biol
Cell. 102:1–12. 2010. View Article : Google Scholar
|
|
27
|
Park YK, Lee J, Hong VS, Choi JS, Lee TY
and Jang BC: Identification of KMU-3, a novel derivative of gallic
acid, as an inhibitor of adipogenesis. PLoS One. 9:e1093442014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Christy RJ, Yang VW, Ntambi JM, Geiman DE,
Landschulz WH, Friedman AD, Nakabeppu Y, Kelly TJ and Lane MD:
Differentiation-induced gene expression in 3T3-L1 preadipocytes:
CCAAT/enhancer binding protein interacts with and activates the
promoters of two adipocyte-specific genes. Genes Dev. 3:1323–1335.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gustafson B, Jack MM, Cushman SW and Smith
U: Adiponectin gene activation by thiazolidinediones requires PPAR
gamma 2, but not C/EBP alpha-evidence for differential regulation
of the aP2 and adiponectin genes. Biochem Biophys Res Commun.
308:933–939. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hwang CS, Loftus TM, Mandrup S and Lane
MD: Adipocyte differentiation and leptin expression. Annu Rev Cell
Dev Biol. 13:231–259. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lakshmanan MR, Nepokroeff CM and Porter
JW: Control of the synthesis of fatty-acid synthetase in rat liver
by insulin, glucagon, and adenosine 3′:5′ cyclic monophosphate.
Proc Natl Acad Sci USA. 69:3516–3519. 1972. View Article : Google Scholar
|
|
32
|
Rubin CS, Hirsch A, Fung C and Rosen OM:
Development of hormone receptors and hormonal responsiveness in
vitro. Insulin receptors and insulin sensitivity in the
preadipocyte and adipocyte forms of 3T3-L1 cells. J Biol Chem.
253:7570–7578. 1978.PubMed/NCBI
|
|
33
|
Gregoire FM, Smas CM and Sul HS:
Understanding adipocyte differentiation. Physiol Rev. 78:783–809.
1998.PubMed/NCBI
|
|
34
|
Fève B: Adipogenesis: Cellular and
molecular aspects. Best Pract Res Clin Endocrinol Metab.
19:483–499. 2005. View Article : Google Scholar : PubMed/NCBI
|
